Helen Swede, PhD

University of Connecticut Health Center

Triple Negative Breast Cancer and Survival Disparity

Awarded $50,000

About the Project: A continuing public health concern in both Connecticut and the rest of the country is that while African American women have a lower rate of breast cancer compared to white women, they are far more likely to die from the disease. This has started more research on Triple Negative Breast Cancer since it has been found in about 30% of tumors in African American Women and less than 10% of tumors in white women. There is evidence which suggests that Triple Negative Breast Cancer has the worst prognosis but it is unclear whether this is because it is more aggressive or because there are no targeted therapies. Dr. Swede will conduct a survival analysis study on patients diagnosed with Triple Negative Breast Cancer which takes into account socioeconomic status, chemotherapy received and other concurrent medical conditions. This will be the largest study of Triple Negative Breast Cancer in the United States to date.